Viridian Therapeutics Inc. (VRDN) NASDAQ

$15.30 0.14 (0.92%)

Market Cap: $951.56M

As of 04/19/24 12:18 PM EDT. Market open.

(VRDN)

Viridian Therapeutics Inc. (VRDN)
NASDAQ

$15.30
0.14 (0.92%)

Market Cap: $951.56M

As of 04/19/24 12:18 PM EDT. Market open.

Add to Portfolio

miragen therapeutics, inc., (nasdaq: mgen), is a biopharmaceutical company discovering and developing innovative microrna (mirna)-targeting therapies to improve human health, specifically in disease areas of high unmet medical need. the company leverages in-house expertise in mirna biology, oligonucleotide chemistry, and drug development to evaluate and advance best-in-class technologies and ... read more

miragen therapeutics, inc., (nasdaq: mgen), is a biopharmaceutical company discovering and developing innovative microrna (mirna)-targeting therapies to improve human health, specifically in disease areas of high unmet medical need. the company leverages in-house expertise in mirna biology, oligonucleotide chemistry, and drug development to evaluate and advance best-in-class technologies and high-potential drug candidates for its own pipeline or in conjunction with strategic partners. at miragen, we recognize the importance of creating strategic relationships within the biotech and pharmaceutical industries and with academic institutions globally. this collaborative approach is making important contributions in our efforts to create mirna-targeting therapies. miragen’s areas of focus include hematological malignancies, pathological fibrosis, neuro-degeneration, and cardiovascular disease. in 2011, the company formed a strategic partnership with servier, a privately-run, french research read less

COMPANY PROFILE
Sector
Health Care and Social Assistance
Industry
Medical Laboratories
CEO
William Marshall
Full Time Employees
112
URL
Address
6200 Lookout Rd, Colorado, Boulder, 80301-3319.
Sector
Health Care and Social Assistance
Industry
Medical Laboratories
CEO
William Marshall
Full Time Employees
112
Address
6200 Lookout Rd, Colorado, Boulder, 80301-3319.
PRICE CHART FOR VIRIDIAN THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$15.26
Previous Close
$15.16
Days Range
$14.99 - $15.35
52 week range
$10.93 - $30.30
Volume
524,969
Avg. Volume (30 days)
758,565
Market Cap
$951.56M
Dividend Yield
-
P/E
(4)
Shares Outstanding
62,767,570
Open
$15.26
Previous Close
$15.16
Days Range
$14.99 - $15.35
52 week range
$10.93 - $30.30
Volume
524,969
Avg. Volume (30 days)
758,565
Market Cap
$951.56M
Dividend Yield
-
P/E
(4)
Shares Outstanding
62,767,570
FINANCIAL STATEMENTS FOR VIRIDIAN THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR VIRIDIAN THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Fairmount Funds Management LLCDirectorJan 22, 2024 Buy$21.00476,1909,999,9901,839,954Jan 24, 2024, 06:44 PM
Meisner LaraChief Legal OfficerJun 16, 2023 Option Exercise$23.032762229,998Jun 20, 2023, 05:23 PM
Meisner LaraChief Legal OfficerJun 15, 2023 Option Exercise$23.032,26952,25532,240Jun 20, 2023, 05:23 PM
Meisner LaraChief Legal OfficerJun 16, 2023 Sale$28.352776529,971Jun 20, 2023, 05:23 PM
Meisner LaraChief Legal OfficerJun 15, 2023 Sale$28.022,26963,57729,971Jun 20, 2023, 05:23 PM
Meisner LaraChief Legal OfficerJun 06, 2023 Option Exercise$18.515,12694,88235,097Jun 06, 2023, 07:41 PM
Meisner LaraChief Legal OfficerJun 05, 2023 Option Exercise$18.514999,23630,470Jun 06, 2023, 07:41 PM
Meisner LaraChief Legal OfficerJun 02, 2023 Option Exercise$14.001,87526,25031,846Jun 06, 2023, 07:41 PM
Meisner LaraChief Legal OfficerJun 05, 2023 Sale$25.0349912,49029,971Jun 06, 2023, 07:41 PM
Meisner LaraChief Legal OfficerJun 02, 2023 Sale$24.211,87545,39429,971Jun 06, 2023, 07:41 PM
Meisner LaraChief Legal OfficerJun 06, 2023 Sale$25.025,126128,25329,971Jun 06, 2023, 07:41 PM
Myers Scott DunsethChief Executive OfficerApr 12, 2023 Buy$25.374,000101,479259,500Apr 12, 2023, 07:05 PM
Myers Scott DunsethChief Executive OfficerMar 13, 2023 Buy$29.155,500160,324255,500Mar 13, 2023, 04:06 PM
Meisner LaraGeneral Counsel and SecretaryMar 09, 2023 Sale$29.0729,971871,2570Mar 10, 2023, 04:05 PM
Violin JonathanChief Executive OfficerFeb 02, 2023 Option Exercise$0.1550,0007,500530,905Feb 07, 2023, 06:35 PM
Violin JonathanChief Executive OfficerFeb 02, 2023 Sale$36.8050,0001,840,000480,905Feb 07, 2023, 06:35 PM
Violin JonathanChief Executive OfficerFeb 02, 2023 Sale$36.8050,0001,840,000430,905Feb 03, 2023, 06:12 PM
Meisner LaraGeneral Counsel and SecretaryJan 23, 2023 Option Exercise$20.566,843140,6906,843Jan 25, 2023, 06:04 PM
Meisner LaraGeneral Counsel and SecretaryJan 23, 2023 Sale$35.666,843244,0210Jan 25, 2023, 06:04 PM
Katz BarrettChief Medical OfficerJan 17, 2023 Option Exercise$23.0324,853572,36524,853Jan 18, 2023, 05:58 PM
Katz BarrettChief Medical OfficerJan 13, 2023 Option Exercise$23.034,14795,5054,147Jan 18, 2023, 05:58 PM
Katz BarrettChief Medical OfficerJan 17, 2023 Sale$37.2124,853924,7800Jan 18, 2023, 05:58 PM
Katz BarrettChief Medical OfficerJan 13, 2023 Sale$37.014,147153,4800Jan 18, 2023, 05:58 PM
Katz BarrettChief Medical OfficerJan 09, 2023 Option Exercise$23.0312,623290,70812,623Jan 11, 2023, 07:09 PM
Katz BarrettChief Medical OfficerJan 10, 2023 Option Exercise$23.0347,3771,091,09247,377Jan 11, 2023, 07:09 PM
Katz BarrettChief Medical OfficerJan 10, 2023 Sale$35.3047,3771,672,4080Jan 11, 2023, 07:09 PM
Katz BarrettChief Medical OfficerJan 09, 2023 Sale$33.0412,623417,0640Jan 11, 2023, 07:09 PM
Meisner LaraGeneral Counsel and SecretaryDec 21, 2022 Option Exercise$23.0316,326375,98816,326Dec 22, 2022, 04:42 PM
Meisner LaraGeneral Counsel and SecretaryDec 20, 2022 Option Exercise$23.0360013,818600Dec 22, 2022, 04:42 PM
Meisner LaraGeneral Counsel and SecretaryDec 21, 2022 Sale$29.1916,326476,5560Dec 22, 2022, 04:42 PM
Meisner LaraGeneral Counsel and SecretaryDec 20, 2022 Sale$28.0760016,8420Dec 22, 2022, 04:42 PM
Meisner LaraGeneral Counsel and SecretaryDec 16, 2022 Option Exercise$23.031,29729,8701,297Dec 19, 2022, 07:22 PM
Meisner LaraGeneral Counsel and SecretaryDec 15, 2022 Option Exercise$23.033006,909300Dec 19, 2022, 07:22 PM
Meisner LaraGeneral Counsel and SecretaryDec 15, 2022 Sale$28.083008,4240Dec 19, 2022, 07:22 PM
Meisner LaraGeneral Counsel and SecretaryDec 16, 2022 Sale$28.441,29736,8870Dec 19, 2022, 07:22 PM
Meisner LaraGeneral Counsel and SecretaryDec 14, 2022 Option Exercise$23.0315,656360,55815,656Dec 14, 2022, 08:56 PM
Meisner LaraGeneral Counsel and SecretaryDec 12, 2022 Option Exercise$23.0360013,818600Dec 14, 2022, 08:56 PM
Meisner LaraGeneral Counsel and SecretaryDec 14, 2022 Sale$28.1215,656440,2470Dec 14, 2022, 08:56 PM
Meisner LaraGeneral Counsel and SecretaryDec 12, 2022 Sale$28.0560016,8300Dec 14, 2022, 08:56 PM
Meisner LaraGeneral Counsel and SecretaryNov 15, 2022 Option Exercise$14.008,125113,7508,125Nov 16, 2022, 06:45 PM
Meisner LaraGeneral Counsel and SecretaryNov 15, 2022 Sale$22.058,125179,1560Nov 16, 2022, 06:45 PM
Fairmount Funds Management LLCDirectorAug 17, 2022 Buy$23.50425,5319,999,9791,363,764Aug 19, 2022, 04:32 PM
Violin JonathanChief Executive OfficerJun 01, 2022 Sale$12.2030,000366,000480,905Jun 02, 2022, 05:29 PM
Violin JonathanChief Executive OfficerMay 02, 2022 Sale$13.0430,000391,200510,905May 04, 2022, 05:23 PM
Violin JonathanChief Executive OfficerApr 01, 2022 Sale$18.9226,400499,488544,505Apr 05, 2022, 06:09 PM
Violin JonathanChief Executive OfficerApr 04, 2022 Sale$18.933,60068,148540,905Apr 05, 2022, 06:09 PM
Violin JonathanChief Executive OfficerMar 02, 2022 Sale$17.3611,106192,800570,905Mar 03, 2022, 04:48 PM
Violin JonathanChief Executive OfficerMar 01, 2022 Sale$17.8218,894336,691582,011Mar 03, 2022, 04:48 PM
Violin JonathanChief Executive OfficerFeb 03, 2022 Sale$19.1690917,416600,905Feb 03, 2022, 06:11 PM
Violin JonathanChief Executive OfficerFeb 02, 2022 Sale$18.4712,340227,920601,814Feb 03, 2022, 06:11 PM
Violin JonathanChief Executive OfficerFeb 01, 2022 Sale$19.5516,751327,482614,154Feb 03, 2022, 06:11 PM
Frazier Life Sciences Public Fund, L.P.10% OwnerSep 23, 2021 Buy$11.00200,0002,200,0001,505,200Sep 28, 2021, 07:46 PM
Fairmount Funds Management LLCDirectorSep 21, 2021 Buy$11.00909,0009,999,000938,233Sep 23, 2021, 09:30 AM
Logos Global Master Fund LP10% OwnerNov 13, 2020 Buy$14.84126,6671,879,599550,000Nov 16, 2020, 06:23 PM
Logos Global Master Fund LP10% OwnerNov 09, 2020 Buy$1.12350,000390,8856,350,000Nov 16, 2020, 06:23 PM
Leverone Jason A.CFO, Treasurer & SecretaryMar 13, 2020 Option Exercise$0.5711,2496,41248,829Mar 17, 2020, 04:22 PM
Leverone Jason A.CFO, Treasurer & SecretaryAug 23, 2019 Option Exercise$0.573,0931,76336,330Aug 23, 2019, 06:16 PM
Hughes Thomas E.DirectorOct 11, 2018 Buy$4.7710,00047,69712,827Oct 12, 2018, 04:38 PM
Leverone Jason A.CFO, Treasurer & SecretaryAug 07, 2018 Option Exercise$0.5729,53016,83230,737Aug 09, 2018, 04:18 PM
Marshall William StuartPresident & CEOFeb 13, 2018 Option Exercise$0.57115,81866,016265,646Feb 15, 2018, 04:36 PM
Levy Adam ScottChief Business OfficerFeb 13, 2018 Buy$5.509,09049,99510,540Feb 13, 2018, 05:02 PM
Booth BruceDirectorFeb 13, 2018 Buy$5.50545,4542,999,9971,351,090Feb 13, 2018, 04:59 PM
Hughes Thomas E.DirectorDec 20, 2017 Sale$8.0012,00096,0002,827Dec 22, 2017, 06:08 PM
Levy Adam ScottChief Business OfficerJun 22, 2017 Buy$7.552001,510200Jun 23, 2017, 07:07 PM
LEFKOFF KYLEDirectorMar 10, 2017 Sale$14.313,30047,229463,473Mar 13, 2017, 06:37 PM
LEFKOFF KYLEDirectorMar 09, 2017 Sale$14.382,50035,961466,773Mar 13, 2017, 06:37 PM
LEFKOFF KYLEDirectorMar 08, 2017 Sale$14.705,00073,514469,273Mar 08, 2017, 05:12 PM
LEFKOFF KYLEDirectorMar 06, 2017 Sale$15.7510,000157,463474,881Mar 08, 2017, 05:12 PM
LEFKOFF KYLEDirectorFeb 28, 2017 Sale$13.542,25830,580484,273Feb 28, 2017, 06:52 PM
LEFKOFF KYLEDirectorFeb 27, 2017 Sale$13.791,50020,687486,531Feb 28, 2017, 06:52 PM
LEFKOFF KYLEDirectorFeb 24, 2017 Sale$14.046,50091,252488,031Feb 28, 2017, 06:52 PM
LEFKOFF KYLEDirectorFeb 23, 2017 Sale$13.651,80024,566494,531Feb 24, 2017, 07:07 PM
LEFKOFF KYLEDirectorFeb 22, 2017 Sale$14.364,10258,886496,331Feb 24, 2017, 07:07 PM
LEBOW BENNETT SDirectorFeb 13, 2017 Option Exercise$5.39279,0671,504,171280,600Feb 13, 2017, 06:05 PM
Gonyer David ADirectorFeb 08, 2017 Option Exercise$7.651,2009,1801,899Feb 08, 2017, 08:50 PM
LEBOW BENNETT SDirectorFeb 03, 2017 Option Exercise$7.651,2009,1801,533Feb 07, 2017, 09:08 PM
Smith Robin LDirectorFeb 03, 2017 Option Exercise$7.651,2009,1801,900Feb 07, 2017, 09:08 PM
SEYMOUR TAMARA ACFO, Secretary, TreasurerOct 31, 2016 Option Exercise$0.3666,54723,957106,447Nov 02, 2016, 08:39 PM
Riccitelli Samuel DPresident & CEOOct 31, 2016 Option Exercise$0.36103,16037,138571,370Nov 02, 2016, 08:37 PM
SEYMOUR TAMARA ACFO, Secretary, TreasurerAug 08, 2016 Option Exercise$0.4910,4845,08526,994Aug 10, 2016, 06:01 PM
Riccitelli Samuel DPresident & CEOJun 28, 2016 Option Exercise$0.4664,83529,824474,530Jun 30, 2016, 04:56 PM
Riccitelli Samuel DPresident & CEOFeb 11, 2016 Option Exercise$0.4654,26824,963415,114Feb 12, 2016, 05:13 PM
Riccitelli Samuel DPresident & CEONov 19, 2015 Buy$0.787,0005,460338,130Nov 23, 2015, 12:28 PM
Riccitelli Samuel DPresident & CEONov 20, 2015 Buy$0.807,0005,600345,130Nov 23, 2015, 12:28 PM
SEYMOUR TAMARA ACFO, Secretary, TreasurerAug 04, 2015 Option Exercise$1.568,52213,29414,478Aug 05, 2015, 05:37 PM
Riccitelli Samuel DPresident and CEOJun 19, 2015 Option Exercise$1.5146,03669,514331,130Jun 23, 2015, 05:35 PM
Riccitelli Samuel DPresident and CEOApr 08, 2015 Option Exercise$2.08119,842249,271252,914Apr 10, 2015, 05:39 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Fairmount Funds Management LLCDirector01/22/20249,999,990
Meisner LaraChief Legal Officer06/16/2023622
Meisner LaraChief Legal Officer06/15/202352,255
Meisner LaraChief Legal Officer06/16/2023765
Meisner LaraChief Legal Officer06/15/202363,577
Meisner LaraChief Legal Officer06/06/202394,882
Meisner LaraChief Legal Officer06/05/20239,236
Meisner LaraChief Legal Officer06/02/202326,250
Meisner LaraChief Legal Officer06/05/202312,490
Meisner LaraChief Legal Officer06/02/202345,394
Meisner LaraChief Legal Officer06/06/2023128,253
Myers Scott DunsethChief Executive Officer04/12/2023101,479
Myers Scott DunsethChief Executive Officer03/13/2023160,324
Meisner LaraGeneral Counsel and Secretary03/09/2023871,257
Violin JonathanChief Executive Officer02/02/20237,500
Violin JonathanChief Executive Officer02/02/20231,840,000
Violin JonathanChief Executive Officer02/02/20231,840,000
Meisner LaraGeneral Counsel and Secretary01/23/2023140,690
Meisner LaraGeneral Counsel and Secretary01/23/2023244,021
Katz BarrettChief Medical Officer01/17/2023572,365
Katz BarrettChief Medical Officer01/13/202395,505
Katz BarrettChief Medical Officer01/17/2023924,780
Katz BarrettChief Medical Officer01/13/2023153,480
Katz BarrettChief Medical Officer01/09/2023290,708
Katz BarrettChief Medical Officer01/10/20231,091,092
Katz BarrettChief Medical Officer01/10/20231,672,408
Katz BarrettChief Medical Officer01/09/2023417,064
Meisner LaraGeneral Counsel and Secretary12/21/2022375,988
Meisner LaraGeneral Counsel and Secretary12/20/202213,818
Meisner LaraGeneral Counsel and Secretary12/21/2022476,556
Meisner LaraGeneral Counsel and Secretary12/20/202216,842
Meisner LaraGeneral Counsel and Secretary12/16/202229,870
Meisner LaraGeneral Counsel and Secretary12/15/20226,909
Meisner LaraGeneral Counsel and Secretary12/15/20228,424
Meisner LaraGeneral Counsel and Secretary12/16/202236,887
Meisner LaraGeneral Counsel and Secretary12/14/2022360,558
Meisner LaraGeneral Counsel and Secretary12/12/202213,818
Meisner LaraGeneral Counsel and Secretary12/14/2022440,247
Meisner LaraGeneral Counsel and Secretary12/12/202216,830
Meisner LaraGeneral Counsel and Secretary11/15/2022113,750
Meisner LaraGeneral Counsel and Secretary11/15/2022179,156
Fairmount Funds Management LLCDirector08/17/20229,999,979
Violin JonathanChief Executive Officer06/01/2022366,000
Violin JonathanChief Executive Officer05/02/2022391,200
Violin JonathanChief Executive Officer04/01/2022499,488
Violin JonathanChief Executive Officer04/04/202268,148
Violin JonathanChief Executive Officer03/02/2022192,800
Violin JonathanChief Executive Officer03/01/2022336,691
Violin JonathanChief Executive Officer02/03/202217,416
Violin JonathanChief Executive Officer02/02/2022227,920
Violin JonathanChief Executive Officer02/01/2022327,482
Frazier Life Sciences Public Fund, L.P.10% Owner09/23/20212,200,000
Fairmount Funds Management LLCDirector09/21/20219,999,000
Logos Global Master Fund LP10% Owner11/13/20201,879,599
Logos Global Master Fund LP10% Owner11/09/2020390,885
Leverone Jason A.CFO, Treasurer & Secretary03/13/20206,412
Leverone Jason A.CFO, Treasurer & Secretary08/23/20191,763
Hughes Thomas E.Director10/11/201847,697
Leverone Jason A.CFO, Treasurer & Secretary08/07/201816,832
Marshall William StuartPresident & CEO02/13/201866,016
Levy Adam ScottChief Business Officer02/13/201849,995
Booth BruceDirector02/13/20182,999,997
Hughes Thomas E.Director12/20/201796,000
Levy Adam ScottChief Business Officer06/22/20171,510
LEFKOFF KYLEDirector03/10/201747,229
LEFKOFF KYLEDirector03/09/201735,961
LEFKOFF KYLEDirector03/08/201773,514
LEFKOFF KYLEDirector03/06/2017157,463
LEFKOFF KYLEDirector02/28/201730,580
LEFKOFF KYLEDirector02/27/201720,687
LEFKOFF KYLEDirector02/24/201791,252
LEFKOFF KYLEDirector02/23/201724,566
LEFKOFF KYLEDirector02/22/201758,886
LEBOW BENNETT SDirector02/13/20171,504,171
Gonyer David ADirector02/08/20179,180
LEBOW BENNETT SDirector02/03/20179,180
Smith Robin LDirector02/03/20179,180
SEYMOUR TAMARA ACFO, Secretary, Treasurer10/31/201623,957
Riccitelli Samuel DPresident & CEO10/31/201637,138
SEYMOUR TAMARA ACFO, Secretary, Treasurer08/08/20165,085
Riccitelli Samuel DPresident & CEO06/28/201629,824
Riccitelli Samuel DPresident & CEO02/11/201624,963
Riccitelli Samuel DPresident & CEO11/19/20155,460
Riccitelli Samuel DPresident & CEO11/20/20155,600
SEYMOUR TAMARA ACFO, Secretary, Treasurer08/04/201513,294
Riccitelli Samuel DPresident and CEO06/19/201569,514
Riccitelli Samuel DPresident and CEO04/08/2015249,271
Load More Insider Transactions
FUNDS WITH A POSITION IN VIRIDIAN THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.3,426,4500.0019%14.48%Other
MAVERICK CAPITAL LTD2,325,8411.02%NewGrowth At A Reasonable Price, Growth
VIVO CAPITAL, LLC1,678,2072.99%No changeOther
YIHENG CAPITAL MANAGEMENT, L.P.1,228,5341.54%No changeOther
GEODE CAPITAL MANAGEMENT, LLC994,4680.00227%15.76%Other
BALYASNY ASSET MANAGEMENT L.P.41,2140.00169%195.04%Event Driven
ALPS ADVISORS INC34,8540.00597%8.03%Other
TUDOR INVESTMENT CORP ET AL30,2180.0053%NewEvent Driven, Other
UBS OCONNOR LLC30,0000.05%-64.64%Value
RENAISSANCE TECHNOLOGIES LLC13,4000.00045%-79.45%Other
CHANGE IN SHARES OUTSTANDING FOR VIRIDIAN THERAPEUTICS INC
STOCK BUYBACKS FOR VIRIDIAN THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
14.19%
1Q
12/31/2023
06/30/2023
15.25%
2Q
12/31/2023
03/31/2023
18.01%
3Q
12/31/2023
09/30/2022
47.74%
5Q
12/31/2023
06/30/2022
79.56%
6Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
14.19%
1Q
06/30/2023
15.25%
2Q
03/31/2023
18.01%
3Q
09/30/2022
47.74%
5Q
06/30/2022
79.56%
6Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR VIRIDIAN THERAPEUTICS INC
LOADING...